Nevada Headache Institute
Las Vegas, Nevada, United States
Neurologist in Las Vegas, Nevada
400 S. Rampart #295, Las Vegas, NV 89145
About Nevada Headache Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
2
Allergan
1
Autonomic Technologies, Inc.
1
H. Lundbeck A/S
1
Pfizer
1
Zosano Pharma Corporation
1
Clinical Trials at Nevada Headache Institute
During the past decade, Nevada Headache Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache
2014-07-01
2020-03-01
Unknown status
120
Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study
2015-12-04
2018-10-05
Completed
986
A Study of Lasmiditan (LY573144) Over Four Migraine Attacks
2019-06-24
2021-07-08
Completed
1,633
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
2018-11-14
2021-02-02
Completed
1,590
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
2018-12-14
2020-06-19
Completed
910
Double-Blind Comparison of the Efficacy and Safety of C213 to Placebo for the Acute Treatment of Cluster Headaches
2019-10-03
2021-04-14
Completed
42
A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of Migraine
2019-11-07
2020-07-08
Completed
485
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Nevada Headache Institute" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "Allergan" with 1 trials
sponsored, "Autonomic Technologies, Inc." with 1 trials sponsored, "H. Lundbeck A/S" with 1 trials sponsored and "Pfizer"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Nevada Headache Institute"
#1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Nevada Headache Institute
According to Clinical.Site data, the most researched conditions in "Nevada Headache Institute" are
"Migraine" (4 trials), "Chronic Cluster Headache" (1 trials), "Cluster Headache" (1 trials) and "Episodic Migraine" (1 trials). Many other conditions were trialed in "Nevada Headache Institute" in a lesser frequency.
Clinical Trials Intervention Types at Nevada Headache Institute
Most popular intervention types in "Nevada Headache Institute" are "Drug" (6 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "ATI Neurostimulation System" (1 trials), "Atogepant" (1 trials), "C213 Microneedle System" (1 trials) and "Eptinezumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Nevada Headache Institute
The vast majority of trials in "Nevada Headache Institute" are
7 trials for "All" genders.
Clinical Trials Status at Nevada Headache Institute
Currently, there are NaN active trials in "Nevada Headache Institute".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Nevada Headache Institute,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Nevada Headache Institute, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".